Harald Hampel, MD, PhD, MA, MSc

Harald Hampel, MD, PhD, MA, MSc

Chief Medical Officer, Senior Vice President, Eisai Inc.
Потвърден имейл адрес: eisai.com
С позовавания в 111960
Drug Discovery & Development Precision Medicine Alzheimer's disease
Karen Bush

Karen Bush

Indiana University Bloomington
Потвърден имейл адрес: indiana.edu
С позовавания в 47049
Antibiotic resistance beta-lactamases drug discovery & development
Alex Zhavoronkov (Aleksandrs Zavoronkovs)

Alex Zhavoronkov (Aleksandrs Zavoronkovs)

Insilico Medicine
Потвърден имейл адрес: insilico.com
С позовавания в 17709
aging and longevity longevity medicine economics of aging and longevity drug discovery & development generative biology & ch
Matthew R Nelson

Matthew R Nelson

Genscience LLC, Deerfield Management
Потвърден имейл адрес: deerfield.com
С позовавания в 15691
Statistical Genetics Drug Discovery & Development
Bino John

Bino John

AstraZeneca
Потвърден имейл адрес: astrazeneca.com
С позовавания в 15305
Biology bioinformatics AI genomics drug discovery & development
Fiona McPhee

Fiona McPhee

Independent Researcher
С позовавания в 13687
Virology Drug Discovery & Development
SNEHASIS JANA

SNEHASIS JANA

Chief Scientific Officer, TSRL
Потвърден имейл адрес: trivedisrl.com
С позовавания в 12492
Drug discovery & Development Nutraceuticals product development Herbal medicines
Giuseppe Astarita

Giuseppe Astarita

Georgetown University
Потвърден имейл адрес: georgetown.edu
С позовавания в 12025
biomarkers lipidomics metabolomics drug discovery & development mass spectrometry
David W. Borhani

David W. Borhani

Ginkgo Bioworks, Inc.
Потвърден имейл адрес: alum.mit.edu
С позовавания в 9154
Drug Discovery & Development Synthetic Biology
Eva Hurt-camejo

Eva Hurt-camejo

Chief Scientist, R&D BiophaPharmaceuticals, AstraZeneca. Adj.Professor, Karolisnka …
Потвърден имейл адрес: astrazeneca.com
С позовавания в 8150
Cardiovascular Drug Discovery & Development
1 - 10